5/31/2011

The FDA approved Optimer Pharmaceuticals' antibiotic Dificid, or fidaxomicin, for treating diarrhea caused by Clostridium difficile. Dificid proved more effective than ViroPharma's vancomycin, a standard antibacterial drug, in sustaining patient response during clinical trials, the agency said.

Related Summaries